TherapeuticsMD Inc. Stock Remains Steady Thursday, Still Outperforms Market

Dow Jones
2024-11-01

DJ TherapeuticsMD Inc. Stock Remains Steady Thursday, Still Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) were unchanged Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.76% to 18,095.15 and Dow Jones Industrial Average falling 0.90% to 41,763.46.

TherapeuticsMD Inc. closed $1.52 short of its 52-week high ($3.07), which the company reached on November 20th.

The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ rose 1.18% to $203.87.

Trading volume (20,033) eclipsed its 50-day average volume of 13,562.

Data source: Dow Jones Market Data, FactSet. Data compiled October 31, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

October 31, 2024 17:32 ET (21:32 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10